Xiaolin Sun

5.5k citations
145 papers · 2.4k indexed · h-index 28

Xiaolin Sun

133 papers receiving 2.4k citations

Peers

Xiaolin Sun
Comparison fields: 5 of 158
  • Rheumatology 503
  • Immunology 657
  • Marketing 157
  • Hematology 178
  • Cancer Research 208
Replace Shuo Hu with:
Shuo Hu China
Arun Sreekumar United States
Xin Duan China
Jonathan Gill United States
Cheng‐Nan Chen Taiwan
Sang Wun Kim South Korea
Dongsheng Zhou China
Eamonn Molloy Ireland
Yuan Tian China
Xiaobing Wang China
Xiaolin Sun relative to Shuo Hu China Shuo Hu's profile →
Citations per field
00.5×4.8×
Shuo Hu · 1×
Citations per year

Countries citing papers authored by Xiaolin Sun

Since Specialization
Citations

This map shows the geographic impact of Xiaolin Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolin Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolin Sun more than expected).

Fields of papers citing papers by Xiaolin Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolin Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolin Sun. The network helps show where Xiaolin Sun may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Xiaolin Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiaolin Sun Line = papers co-authored together Xiaolin Sun links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20250
3 20240
4 20242
5 202413
6 20241
7 20234
8 20235
9 202230
10 202229
11 20218
12 202018
13 201917
14 201927
15 20188
16
Lipopolysaccharide-binding protein is a sensitive disease activity biomarker for rheumatoid arthritis.
201823
17 201866
18 201811
19 201717
20 19947

About Xiaolin Sun

Xiaolin Sun is a scholar working on Rheumatology, Immunology, Radiology, Nuclear Medicine and Imaging, Genetics and Hematology, having authored 145 papers that have together received 2.4k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (31 papers), T-cell and B-cell Immunology (22 papers), Monoclonal and Polyclonal Antibodies Research (19 papers), Salivary Gland Disorders and Functions (15 papers), Rheumatoid Arthritis Research and Therapies (11 papers), Inflammatory Myopathies and Dermatomyositis (9 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Immune Cell Function and Interaction (6 papers). The work is most often cited by research in Rheumatology (503 citations), Immunology (657 citations), Marketing (157 citations), Hematology (178 citations) and Cancer Research (208 citations). Xiaolin Sun has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Zhanguo Li, Yajiong Xue, Juanru Wang, Yang Jin, Jing He, Hong Xin, Yuzhou Gan, Yuhui Li, Peng Li and Miao Shao. Their work appears in journals such as Clinical and Experimental Rheumatology, Clinical Rheumatology, Journal of Immunology Research, Frontiers in Medicine and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026